论文部分内容阅读
目的：探讨国产长春西汀片治疗脑梗死恢复期患者的效果及对血液流变学指标的影响，并与进口同类药物进行对比。方法将104例患者随机分为治疗组（n=75）和对照组（n=29）。治疗组应用国产长春西汀片5 mg/次，3次/d口服。对照组应用卡兰片5 mg/次，3次/d口服。两组疗程均为4周。监测2组血液流变学指标。结果国产长春西汀片对脑梗死恢复期的总有效率为62.7%，对照组总有效率为62.1%，二者差异无统计学意义（P＞0.05）。两组对自觉症状的疗效差异亦无统计学意义（P＞0.05）。两组治疗后血液流变学各项指标较治疗前均有明显下降（P＜0.05或P＜0.01）。无明显不良反应。结论国产长春西汀片治疗脑梗死恢复期有效，可降低血液流变学各项指标，改善血液的高凝、高聚状态，且与进口同类药物相比疗效无显著差别。“,”Objective To investigate the therapeutic effect of national vinpocetine on patients with cerebral infarction at recovery stage and its effect on their hemorheological parameters. Methods 104 patients were di-vided into treatment group (n=75) and control group (n=29) randomly. The treatment group was administered with national vinpocetine 5 mg tid orally for 4 weeks, while the control group administered with imported vinpocetine. Hemorheological parameters were monitored in the two groups. Results The total effective rate of treatment group on recovery-stage cerebral infarction was 62.7%, without signiifcant difference with control group (62.1%, P>0.05). No signiifcant difference was found with the effect on the subjective symptoms between the two groups (P>0.05). Values of hemorheological indicators decreased signiifcantly after treatment in both groups (P<0.05 or P<0.01). No obvious adverse effects were observed. Conclusion National vinpocetine is effective for the treatment of recovery-stage cerebral infarction and can reduce the blood viscosity of patients.